Myoung-Don Oh to Anthrax
This is a "connection" page, showing publications Myoung-Don Oh has written about Anthrax.
Connection Strength
0.196
-
Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study. Vaccine. 2019 06 27; 37(29):3820-3824.
Score: 0.196
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.